Back to News
Market Impact: 0.2
Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value
Source: Bloomberg
Artificial IntelligenceHealthcare & BiotechPrivate Markets & Venture
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet’s Google DeepMind, is in early talks to raise new funding at a valuation of at least $40 billion, according to people familiar with the effort. The discussions are preliminary; no funding amount or completed deal was reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
GOOG0.40
More News
- Is AI the new China Shock?
- Wall Street is pitching data centers as a major real estate bet. The risks are piling up
- Ukraine’s drones knock out AI data center belonging to "Russia’s Google"
- ‘Trojan horse’: California’s top 1% pay nearly half the state’s income taxes. Prop 40 opponents warn the billionaire tax could reach everyone else
- AI-related companies to drive most third-quarter US earnings gains
- Stock bull market nears 4-year anniversary driven by AI spending — but there are looming risks
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Automating Financial Model Updates: A Source-Controlled Workflow
- Weekly Update: Live Event Center, In-App Documents, and Faster Transcripts